January 13, 2021
Novartis has published results from a clinical trial of Pear Therapeutics' new digital therapeutic for schizophrenia, and the results don't paint a rosy picture.
The single-blinded 112-person trial found no difference between the Pear app and a placebo app in any outcome measure, including the primary outcome measure of reducing schizophrenia symptoms. However, the trial did further establish the...
August 28, 2020
It’s no secret that digital is shaping what clinical trials will look like in the future. A recently published position paper published in Nature discusses the potentials and challenges of digital clinical trials. The paper builds on a workshop held by the U.S. National Institutes of Health and the National Science Foundation in April of 2019.
One of the big opportunities that the paper outlines...
June 12, 2020
In the recent Veeva European R&D Summit, focus was paid to how the COVID-19 emergency and its accompanying reorganisation of healthcare provision has forced the pharmaceutical industry to rethink the way it conducts research and development.
In an exclusive interview with MobiHealthNews, Henry Levy, general manager of Veeva Vault clinical data management system (CDMS), site and patient...
March 26, 2020
Yesterday morning ClinOne, a digital platform that helps researchers manage clinical trials, landed $3.6 million in Series A funding. The infusion of cash was led by CU Healthcare Innovation Fund.
WHAT THEY DO
The platform works with pharma companies, research groups, and clinical trial sites in order to recruit appropriate patients for their trial.
Researchers can use the platform to manage ...
February 4, 2020
Inato, a Parisian startup revamping clinical trial enrollment, has pulled in a $14 million Series A round. Obvious Ventures and Cathay Innovation headed the raise, which also saw support from prior backers Serena and Fly Ventures.
WHAT THEY DO
Inato has developed a platform that helps biopharma clients select the optimal site for their clinical studies. Its technology incorporates logistical data...
January 30, 2020
This morning, Massachusetts General Hospital (MGH), Google Cloud and digital clinical trial startup ProofPilot inked a deal to create a new clinical research platform targeted at academic medical centers and universities.
The trio plan to kick off this new platform with a study called “Piloting Time-Restricted Feeding (TRF) for Bipolar Disorder” at MGH.
The new collaboration will tap into...
Photo courtesy of Janssen Pharmaceutical Companies. From left to right: panel moderator Patrick Wayte, Dr. C. Michael Gibson and Dr. Paul Stoffels.
November 18, 2019
Due to the promises of lower costs, simple scaling and greater patient engagement, digital technologies are all but an inevitability for the drug trials of tomorrow, according to experts from pharma and the clinical research community speaking this weekend at the American Heart Association Scientific Sessions in Philadelphia.
These comments were accompanied by the official kickoff of CHIEF-HF,...
November 7, 2019
AiCure, a nearly decade-old startup using artificial intelligence to measure medication adherence and other behavior during clinical trials or normal care, has brought in $24.5 million in Series C funding.
Palisades Growth Capital led the raise, which also featured new backers Singtel Innov8, Asahi Kasei Corporation, Accelmed Growth Partners, and SpringRock Ventures. The round also included all...
September 11, 2019
When it comes to clinical trials, oftentimes the majority of a patient’s experience happens “off stage” in their home or community. For example, medication adherence, or nonadherence, has been a major pitfall in medicine. Studies have found that roughly one in five new prescriptions are never filled, and of those filled up to 50% are taken incorrectly.
Startups have taken notice and the digital...
July 31, 2019
Litmus Health announced yesterday the release of a new version of its device-friendly clinical research platform for the collection and analysis of real-world data.
Built with new features to help pharmaceutical companies from the beginning to the end of their drug trials, the platform now adds Actigraph’s medical-grade wearables to its repertoire of supported devices, which previously included...